αvβ6-integrin targeted PET/CT imaging in pancreatic cancer patients using 68Ga-Trivehexin
<sup>68</sup>Ga-Trivehexin is suitable for imaging of αvβ6-integrin expression in pancreatic cancer due to its ability to distinguish primary carcinoma and metastases from background tissue.
Authors
- Johannes Notni (ORCID: https://orcid.org/0000-0002-3964-3391)
- Robert Winzer (ORCID: https://orcid.org/0000-0002-6650-3992)
- Gunnar Folprecht (ORCID: https://orcid.org/0000-0002-9321-9911)
- Marius Distler (ORCID: https://orcid.org/0000-0002-3164-5755)
- Sebastian Hempel (ORCID: https://orcid.org/0000-0003-4268-9902)
- Marc Pretze (ORCID: https://orcid.org/0000-0002-6432-5694)
- J Rehm (ORCID: https://orcid.org/0009-0002-2960-1996)
- Juliane Müller (ORCID: https://orcid.org/0000-0002-8279-0901)
- Jörg Kotzerke
Institutions
- Trimble (Germany) (DE)
- Technische Universität Dresden (DE)
Publication Details
- Journal
- Frontiers in Nuclear Medicine
- Published
- 2024-11-15
- DOI
- https://doi.org/10.3389/fnume.2024.1487602
- Citations
- 10
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 2.83